27 GX-188E, A Therapeutic HPV Vaccine, in Combination with Imiquimod or IL-7-HYFC for Treatment of HPV-16 or HPV-18 Related Cin 3: Results from Phase 2 Study

J. S. Park, S. J. Lee,S. Y. Hur, T. J. Kim,S. R. Hong, J. K. Lee,C. H. Cho,Y. S. Suh, J. W. Woo,Y. C. Sung

International Journal of Gynecological Cancer（2019）

引用 0|浏览2

暂无评分

摘要

Objectives We conducted a prospective, randomized, phase 2 clinical trial of GX-188E, a therapeutic HPV vaccine in combination with Imiquimod (IMQ) or IL-7-hyFc for HPV-16 or -18 related CIN 3. The primary endpoint was to determine the histopathological regression to 更多

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要